#### ![calendar-Icon](/themes/custom/cosmos/patterns/images/calendar-v2.svg)October 26, 2021

 

 #### Basel, Switzerland

 

 

Novartis announced the company’s financial results for the third quarter of 2021.

 

 

 [    Media release  (271 KB)   ](https://www.novartis.com/sites/novartis_com/files/q3-2021-media-release-en.pdf) [    Medienmitteilung  (273 KB)   ](https://www.novartis.com/sites/novartis_com/files/q3-2021-media-release-de.pdf) [    Communiqué de presse  (423 KB)   ](https://www.novartis.com/sites/novartis_com/files/q3-2021-media-release-fr.pdf) 

 



 [    Interim financial report  (481 KB)   ](https://www.novartis.com/sites/novartis_com/files/2021-10-interim-financial-report-en.pdf) 

 



 [ 

 

###  Executive Committee of Novartis (ECN) Biographies 

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies.

 

 

 ](/about/executive-committee) [ 

 

###  Novartis Pipeline 

Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines.

 

 

 ](https://www.novartis.com/research-development/novartis-pipeline)